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SUMMARY
Deamidation of N-terminal Gln by NtQ-amidase, a previously undescribed N-terminal
amidohydrolase, is a part of the N-end rule pathway of protein degradation. We detected the activity
of NtQ-amidase, termed Ntaq1, in mouse tissues, purified Ntaq1 from bovine brains, identified its
gene, and began analyzing this enzyme. Ntaq1 is highly conserved among animals, plants and some
fungi, but its sequence is dissimilar to sequences of other amidases. An earlier mutant in the
Drosophila Cg8253 gene that we show here to encode NtQ-amidase has defective long-term memory.
Other studies identified protein ligands of the uncharacterized human C8orf32 protein that we show
here to be the Ntaq1 NtQ-amidase. Remarkably, “high-throughput” studies have recently solved the
crystal structure of C8orf32 (Ntaq1). Our site-directed mutagenesis of Ntaq1 and its crystal structure
indicate that the active site and catalytic mechanism of NtQ-amidase are similar to those of
transglutaminases.
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INTRODUCTION
The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal residue
(reviewed by (Mogk et al., 2007; Tasaki and Kwon, 2007; Varshavsky, 1996, 2008a;
Varshavsky, 2008b). Degradation signals (degrons) that can be targeted by the N-end rule
pathway are of two “topologically” distinct kinds: N-terminal degrons, called N-degrons, and
internal (non-N-terminal) degrons (Ravid and Hochstrasser, 2008; Varshavsky, 1996; Wang
et al., 2008). The main determinant of an N-degron is a destabilizing N-terminal residue of a
substrate protein (Figure 1A). The other determinants of N-degron are a substrate’s internal
Lys residue (the site of formation of a poly-Ub chain) and a nearby unstructured region
(Bachmair and Varshavsky, 1989; Prakash et al., 2009; Suzuki and Varshavsky, 1999). An N-
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degron is produced from a precursor, called a pre-N-degron, through a protease-mediated
cleavage of a substrate that exposes a destabilizing N-terminal residue.
E3 Ub ligases of the N-end rule pathway, called N-recognins, are defined as E3s that can
recognize (target) at least some N-degrons (Figure 1A) (Tasaki and Kwon, 2007; Varshavsky,
1996). Some of substrate-binding sites of an N-recognin target N-degrons of specific substrates,
while other sites of the same N-recognin target internal (non-N-terminal) degrons of other
protein substrates. At least four N-recognins, Ubr1, Ubr2, Ubr4 and Ubr5, mediate the N-end
rule pathway in mammals and other multicellular eukaryotes (Figure 1A) (Tasaki and Kwon,
2007; Tasaki et al., 2009). The N-end rule pathway of the yeast Saccharomyces cerevisiae is
mediated by a single N-recognin, Ubr1, a 225-kDa sequelog of mammalian Ubr1 and Ubr2
(Hwang et al., 2009; Hwang and Varshavsky, 2008; Xia et al., 2008b). (A note on
terminology: “sequelog” and “spalog” denote, respectively, a sequence that is similar, to a
specified extent, to another sequence, and a 3D structure that is similar, to a specified extent,
to another 3D structure. Besides their usefulness as separate terms for sequence and spatial
similarities, the rigor-conferring advantage of “sequelog” and “spalog” is their evolutionary
neutrality, in contrast to interpretation-laden terms such as “homolog”, “ortholog” and
“paralog” (Varshavsky, 2004).)
The functions of the N-end rule pathway (Figure 1A) include selective degradation of
misfolded proteins; the sensing of nitric oxide (NO), oxygen, heme, and short peptides; the
fidelity of chromosome segregation; the control of peptide import; regulation of signaling by
transmembrane receptors, through the NO/O2-controlled degradation of specific RGS proteins
that regulate G proteins; regulation of DNA repair, apoptosis, meiosis, spermatogenesis,
neurogenesis, and cardiovascular development; the functioning of specific organs, in particular
the brain and the pancreas; and regulation of leaf senescence, seed germination, and other
processes in plants ((Eisele and Wolf, 2008; Holman et al., 2009; Hu et al., 2005; Hu et al.,
2008; Hwang et al., 2009; Hwang and Varshavsky, 2008; Rao et al., 2001; Tasaki and Kwon,
2007; Varshavsky, 2008a; Xia et al., 2008a; Zenker et al., 2005), and refs. therein).
The N-end rule has a hierarchic structure (Figure 1A). N-terminal Asn and Gln are tertiary
destabilizing residues in that they function through their enzymatic deamidation, to yield the
secondary destabilizing N-terminal residues Asp and Glu (Baker and Varshavsky, 1995; Kwon
et al., 2000). Destabilizing activity of N-terminal Asp and Glu requires their conjugation to
Arg, one of the primary destabilizing residues, by the ATE1-encoded Arg-tRNA-protein
transferase (R-transferase) (Hu et al., 2005; Hu et al., 2008; Kwon et al., 2002). In mammals
and other eukaryotes that produce NO, the set of arginylated residues contains not only Asp
and Glu but also N-terminal Cys, which is arginylated after its oxidation to Cys-sulfinate or
Cys-sulfonate, in reactions that require NO, oxygen (O2) or their derivatives (Figure 1A) (Hu
et al., 2005; Tasaki and Kwon, 2007).
In S. cerevisiae, the deamidation branch of the N-end rule pathway is mediated by the Nta1
NtN,Q-amidase, which can deamidate either Asn or Gln at the N-termini of polypeptide
substrates (Baker and Varshavsky, 1995). In mammals and other multicellular eukaryotes, N-
terminal Asn and Gln are deamidated by N-terminal amidases (Nt-amidases) of two kinds
(Figure 1A). One of them, the previously characterized Ntan1 NtN-amidase, is specific for N-
terminal Asn (Grigoryev et al., 1996). In part through analyses of Ntan1−/− mice, which could
not deamidate N-terminal Asn (Kwon et al., 2000), it has been inferred that there also exists a
Gln-specific NtQ-amidase.
In the present work, we detected the activity of NtQ-amidase, termed Ntaq1, in mouse tissues,
purified Ntaq1 from bovine brains, identified its gene, and began studies of this previously
undescribed enzyme (Figure 1A). The sequence of mouse Ntaq1 (NtQ-amidase) is highly
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conserved among animals, plants and some fungi, but is dissimilar to sequences of other
amidases, including the N-terminal amidases Ntan1 (NtN-amidase) and Nta1 (NtN,Q-amidase).
A tungus mutant in the previously uncharacterized Drosophila melanogaster Cg8253 gene was
found to have defective long-term memory (Dubnau et al., 2003). We show here that this
Drosophila gene encodes the counterpart of mouse Ntaq1. In addition, previous proteomic
studies identified ~15 putative protein ligands of an uncharacterized human protein encoded
by C8orf32 ((Lim et al., 2006) and refs. therein). We show here that C8orf32 is the human
Ntaq1 NtQ-amidase. Remarkably, “high-throughput” crystallographic studies of human
proteins have recently solved the crystal structure of C8orf32 (Ntaq1) (Bitto et al., 2008). In
conjunction with its crystal structure, our site-directed mutagenesis of Ntaq1 indicates that the
active site and catalytic mechanism of NtQ-amidase are similar to those of transglutaminases.
Thus, the discovery and study of NtQ-amidase as a component of the N-end rule pathway
(Figure 1A) were “instantly” complemented by a crystal structure of this enzyme, a set of its
putative protein ligands, and evidence for its role in memory processes.
RESULTS
The S. cerevisiae Nta1 NtN,Q-amidase (Baker and Varshavsky, 1995) (Figure S1) belongs to
the nitrilase superfamily, defined through sequelogies (sequence similarities) and spalogies
(spatial similarities) (Varshavsky, 2004) among its members. Mammalian Ntan1 NtN-
amidases, which can deamidate N-terminal Asn but not N-terminal Gln (Grigoryev et al.,
1996), are not sequelogous to yeast Nta1. Initially, we attempted a bioinformatics-based
identification of a putative NtQ-amidase, termed Ntaq1. Several (weak) sequelogs of mouse
Ntan1 or S. cerevisiae Nta1 were identified in the mouse genome, but none of those proteins,
when expressed in nta1Δ S. cerevisiae, were able to restore the Gln-specific branch of the N-
end rule pathway in that mutant (data not shown). The resulting impasse led to a direct-isolation
approach (Figure 1B, C).
Detection of Mouse NtQ-Amidase and Purification of Bovine NtQ-Amidase
Reporters for the NtQ-amidase assay (Figure 1B and Figure S2A) comprised the E. coli
dihydrofolate reductase (DHFR) moiety fused to a C-terminal peptide (denoted as “bt”) that
was biotinylated in vivo, and also the N-terminal His10-Ub moiety followed by a sequence
derived from the N-terminal sequence of α-lactalbumin (Hu et al., 2008). The resulting set of
reporters, His10-Ub-X-(LTKCEV)-DHFRbt (X = Q; E; N; EQ; MQ; GQ; REQ) is denoted as
His10-Ub-X-DHFRbt. A purified His10-Ub-X-DHFRbt was immobilized, via its C-terminal
biotin moiety, on neutravidin beads, and thereafter treated with purified USP2cc
deubiquitylating enzyme to remove N-terminal His10-Ub, followed by incubation with a cell
extract. The resulting samples were washed and incubated with purified R-transferase and
radiolabeled Arg, followed by SDS-PAGE and autoradiography of a reporter (Figure 1B,
Figure 2A–C and Figure S2).
This assay (Figure 1B) detected varying levels of NtQ-amidase activity in all mouse tissues
examined (Figure 2A, B and Figure S2). Control assays included incubations of immobilized
X-DHFRbt reporters with buffer alone, before the addition of R-transferase (Figure 2B). The
NtQ-amidase activity was detected by comparing the arginylation of Glu-DHFRbt, a substrate
of R-transferase (Figure 1A), to the arginylation of Gln-DHFRbt, which can be arginylated
only after its N-terminal deamidation (Figure 1B and Figure 2A, B). Yet another control
involved pre-heating of brain extracts at 95°C for 5 min. Glu-DHFRbt could be arginylated by
the (subsequently added) R-transferase irrespective of whether a brain extract was heated or
unheated before incubation with this reporter. In contrast, the same test with Gln-DHFRbt
resulted in a negligible arginylation if a heated brain extract was used (data not shown),
implying that deamidation of Gln-DHFRbt was an enzymatic reaction. The non-reporter bands
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of 14C-labeled (arginylated) proteins were endogenous proteins that cofractionated with
neutravidin beads (Figure 2A and Figure S2B). Some of these proteins might be physiological
substrates of R-transferase.
Having detected NtQ-amidase (Ntaq1), we developed a procedure for its purification from calf
brains that included ammonium sulfate precipitation of proteins from a brain extract, followed
by ion exchange, hydrophobic and gel filtration chromatography (Figure 1C, Figure 2C and
Figure S3A, B). In the last step, a gel filtration on a Superose-12 column, the Ntaq1 NtQ-
amidase activity migrated as a symmetric peak at ~26 kDa (vis-a-vis globular proteins as Mr
standards) (Figure 2C). Silver staining of SDS-PAGE-fractionated proteins from peak activity
fractions showed two nearly comigrating major bands, the lower band being more abundant in
the peak activity fraction (Figure 2C, D). The two proteins were separately excised from the
gel and partially sequenced, using in-gel digestion with trypsin and mass spectrometry (MS)
(Figure 2D). The upper band was identified as the bovine counterpart of the human heme-
binding protein HEBP2. The lower band was identified as the 207-residue bovine counterpart
of human C8orf32 (FLJ10204), a previously inferred 205-residue (24-kDa) protein of unknown
function (Figure 2D).
Identification and Characterization of the Mouse Ntaq1 NtQ-Amidase
Mouse Hebp2 cDNA and Wdyhv1 cDNA (Acc. No. NC_000081.5) (the latter is the counterpart
of human C8orf32 (FLJ10204) cDNA) were subcloned into the plasmid p425Met25. The
FLAG-tagged mouse Hebp2f and Wdyhv1f were expressed in an nta1Δ mutant of S. cerevisiae
that lacked the endogenous Nta1 NtN,Q-amidase, and cell extracts were examined using the
NtQ-amidase assay described in Figure 1B. Although mouse Hebp2f and Wdyhv1f were
expressed in S. cerevisiae at comparable levels, as determined by SDS-PAGE and
immunoblotting with anti-FLAG antibody, only extracts from cells that expressed Wdyhv1f
exhibited the NtQ-amidase activity (data not shown). To verify the conclusion that Wdyhv1f
was the Ntaq1 NtQ-amidase (Figure 1A), we examined Wdyhv1f in vivo as well, using
nta1Δ S. cerevisiae that carried plasmids expressing Ub-X-β-galactosidases (Ub-X-βgals), a
set of reporters in which X was a variable residue. Cotranslational deubiquitylation of these
Ub fusions produces X-βgal reporter proteins. Their enzymatic activity can be employed to
compare metabolic stabilities of these (otherwise identical) reporters bearing different N-
terminal residues (Baker and Varshavsky, 1995; Varshavsky, 2005).
As would be expected (Figure 1A), the levels of Asp-βgal and Glu-βgal (their degradation does
not require deamidation) were low in all of the tested genetic backgrounds, signifying short in
vivo half-lives of these X-βgals, whereas the levels of long-lived Met-βgal were high in the
same backgrounds (Figure 3A–D). The levels of Asn-βgal and Gln-βgal were high in nta1Δ
cells but could be made low by re-introduction of yeast NTA1 encoding NtN,Q-amidase (Figure
3A, D). Crucially, the levels of Gln-βgal were high in nta1Δ S. cerevisiae but became low in
the presence of the mouse Ntaq1f NtQ-amidase (Figure 3A, B). A “reciprocal” result was
obtained with nta1Δ cells that expressed the previously characterized mouse Ntan1 NtN-
amidase (Figure 3A, C). Thus, mouse Ntaq1 and Ntan1 are specific for N-terminal Gln and N-
terminal Asn, respectively, but not for both of these residues, in contrast to S. cerevisiae Nta1.
These in vivo results, in agreement with the in vitro data cited above, confirmed the
identification of mouse Ntaq1 as an NtQ-amidase.
Depletion of Mouse Ntaq1 in Vivo and in Cell Extracts
A plasmid that expressed a mouse Ntaq1-EGFP fusion from the PCMV promoter was transiently
transfected into NIH-3T3 cells. The resulting fluorescence patterns (Figure S3C–H) suggested
a cytosolic/nuclear location of Ntaq1. One caveat is that Ntaq1-EGFP was overexpressed in
comparison to the endogenous Ntaq1 NtQ-amidase. The endogenous Ntaq1 gene is expressed,
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at varying levels, in most cell types, given the presence of NtQ-amidase activity in all mouse
tissues examined (Figure 2A–D and S2). In agreement with this conclusion, the data in Allen
Brain Atlas (http://www.brain-map.org/) indicate that Ntaq1 mRNA (denoted as Cg8253 in
the Atlas) is expressed, at varying levels, throughout the mouse brain.
A mouse gene (Acc. No. NC_000081.5), termed Ntaq1 in the present work, is located on
Chromosome 15, is ~17.2 kb long, contains 6 exons, and encodes the 209-residue (24-kDa)
Ntaq1 NtQ-amidase (Figure 4A). The mouse genome does not contain statistically significant
sequelogs of mouse Ntaq1, suggesting (but not proving) that Ntaq1 is the sole source of NtQ-
amidase at least in mammals. Given the in vitro and in vivo evidence described above (Figure
1–Figure 3), it was expected that a down-regulation of Ntaq1 in mouse cells would result in a
decrease of NtQ-amidase activity. To verify this expectation, we carried out RNAi with mouse
NIH-3T3 cells that expressed Ntaq1-specific pre-microRNA (pre-miRNA), and indeed
observed a significant decrease of the in vivo levels of both the NtQ-amidase activity and the
Ntaq1 protein, in comparison to control cells (Figure S4A, B; see Experimental Procedures
and the legend to Figure S4 for details). This decrease could be detected either by carrying out
the NtQ-amidase activity assay with extracts of RNAi-treated and mock-treated cells (Figure
S4A), or by immunoblotting the same extracts with an affinity-purified rabbit anti-Ntaq1
antibody, raised against purified mouse Ntaq1 that was produced in the yeast Pichia pastoris
(Figure 2E and Figure S4B).
In a different, in vitro-based approach, we selectively depleted Ntaq1 from cell extracts, using
the above affinity-purified anti-Ntaq1 antibody. A depletion of endogenous Ntaq1 from
extracts of NIH-3T3 cells with the antibody to Ntaq1 resulted in extracts that did not contain
NtQ-amidase activity above “nonspecific” (control) backgrounds, whereas the otherwise
identical treatment of cell extracts with preimmune serum did not significantly decrease this
activity (Figure 5A and Figure S4C–E). In agreement with the absence of (statistically
significant) sequelogs of mouse Ntaq1 in the mouse genome, the effect of Ntaq1-specific RNAi
on the activity of NtQ-amidase and a similar but even stronger effect of depleting Ntaq1 with
anti-Ntaq1 antibody (Figure 5A and Figure S4) suggested (but did not prove) that Ntaq1 is the
sole NtQ-amidase in the mouse.
Substrate Specificity of Ntaq1 NtQ-Amidase
The NtQ-amidase assay (Figure 1B) was applied to C-terminally His6-tagged, purified mouse
Ntaq1 (Ntaq1H6) that was expressed in the yeast P. pastoris (Figure 2E). The results confirmed
the Gln-specific NtQ-amidase activity of Ntaq1 (Figure 5B), and also indicated that Ntaq1
could be inhibited by thiol-specific reagents such as iodoacetamide or N-ethylmaleimide (data
not shown). To address the properties of Ntaq1 in yet another way, X-(LTKCEV)-DHFRbt
reporters (X = Q; N; E; MQ; GQ; EQ) were incubated with purified mouse Ntaq1H6, followed
by N-terminal sequencing of the resulting proteins by Edman degradation. Gln-((LTKCEV)-
DHFRbt became Glu-(LTKCEV)-DHFRbt after incubation with Ntaq1, whereas Asn-
(LTKCEV)-DHFRbt, Glu-(LTKCEV)-DHFRbt, Met-Gln-(LTKCEV)-DHFRbt, Gly-Gln-
(LTKCEV)-DHFRbt, and Glu-Gln-(LTKCEV)-DHFRbt remained unchanged (Figure 3F).
These experiments directly demonstrated that Ntaq1 is an NtQ-amidase, and also showed that
Gln at position 2 was not a substrate of Ntaq1, confirming its high specificity for N-terminal
Gln (Figure 5C).
At this stage of the project, we developed an entirely different NtQ-amidase assay, which
utilized purified Ntaq1 and 7-residue synthetic peptides XY-GSGAW (XY = QH; QK; QL;
QD; QY; QP; KQ; YH; NH; Ac-QH) as reporters (Figure 4B, C). In this “Q-peptide” assay,
deamidation of, for example, Gln-HGSGAW was measured by quantifying the production of
ammonia (NH3). It was detected through the presence of NADH-dependent glutamate
dehydrogenase (Figure 4B). The consumption of NADH, monitored through a decrease of
Wang et al. Page 5
Mol Cell. Author manuscript; available in PMC 2010 June 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
A340, was used to measure the formation of ammonia and thus the activity of purified NtQ-
amidase. In agreement with the inferred specificity of Ntaq1 for the unmodified N-terminal
Gln of a polypeptide, the Q-peptide assay showed that Ntaq1 could not deamidate acetylated
N-terminal Gln, and was also inactive toward non-Gln N-terminal residues (Figure 4C). With
the sole exception of proline, all tested second-position residues did not influence the activity
of Ntaq1 by more than 2-fold (Figure 4C). In contrast, a Pro at position 2, in the QPGSGAW
peptide, virtually abolished deamidation of N-terminal Gln (Figure 4C), a potential clue to
stereochemistry and mechanism of NtQ-amidase.
Three-Dimensional Structure, Mutational Analysis, and Mechanism of Ntaq1 NtQ-Amidase
Strong sequelogs of the mouse, human and bovine Ntaq1 NtQ-amidases are present throughout
the animal kingdom (including fishes, insects and nematodes), in plants (including Arabidopsis
thaliana), and in some fungi, such as the fission yeast Schizosaccharomyces pombe, but not in
the budding yeast S. cerevisiae (Figure S5). (S. cerevisiae contains the Nta1 NtN,Q-amidase
(Figure S1).) Although Ntaq1 of the present work and the previously characterized Ntan1
(Kwon et al., 2000) catalyze analogous reactions (Figure 1A), there is no statistically significant
sequelogy among Ntaq1, Ntan1 and Nta1. This remarkable lack of sequelogy suggests
independent origins of these Nt-amidases, presumably late in evolution of the N-end pathway,
after the emergence of its arginylation branch (Figure 1A). In contrast to Nt-amidases, there is
a sequelogy between eukaryotic Ate1 R-transferases (Figure 1A) and prokaryotic Bpt L-
transferases (Graciet et al., 2006), suggesting that beginnings of the N-end rule’s arginylation
branch predate the emergence of eukaryotes.
While preparing this study for publication we came across a recent entry in the Protein Data
Bank (PDB #3C9Q; target name: BC008781) (Bitto et al., 2008). This entry, a part of “high-
throughput” crystallographic studies by the Center for Eukaryotic Structural Genomics,
described the crystal structure of the otherwise uncharacterized C8orf32 human protein (Figure
6A). As shown by our findings (Figure 2–Figure 5, Figure S2–S4, and discussion above), the
mouse Ntaq1 NtQ-amidase is the counterpart of human C8orf32. Consequently, C8orf32 will
now be called Ntaq1. The 1.5 Å structure of human Ntaq1 (C8orf32), solved with a bound
peptide-like compound with a well-resolved N-terminal tripeptide Ser-Thr/Val-Ala (Bitto et
al., 2008), is a monomeric globular protein of a novel structural fold, with an α-β-α three-layer
sandwich architecture (Figure 6A). The residues Cys28, His81 and Asp97 (they correspond to
Cys30, His83 and Asp99 in mouse Ntaq1) are highly conserved among Ntaq1 proteins of
different organisms (Figure S4) and are spatially proximal in the crystal structure of human
Ntaq1 (Figure 6C), in a region that resembles an active site, in proximity to the bound peptide-
like compound (Bitto et al., 2008).
Guided by Ntaq1 sequence alignments (Figure S5) and the crystal structure of human Ntaq1
(Figure 6A), we used site-directed mutagenesis and expression in the yeast P. pastoris to
produce and purify 9 mutants of mouse Ntaq1, in addition to wild-type enzyme (Figure 2E and
data not shown). The results of examining these mutants by the Q-peptide assay were in
agreement with the inferred significance of Cys30 and His83 as key residues of the active site
(Figure 4D). Specifically, Ntaq1C30A and Ntaq1H83A had no detectable NtQ-amidase activity,
in contrast to wild-type or nearly wild-type levels of activity exhibited by mutants at other
evolutionarily conserved positions, such as Ntaq1C23A, Ntaq1C28A, Ntaq1C-38A, Ntaq1E39Q,
and Ntaq1H170A (Figure 4E). The Ntaq1D81N mutant was impaired but still active (Figure 4D).
An analogous Cys…His…Asp triad of spatially proximal residues mediates the catalysis by
cysteine proteases (such as, for example, papain), and by transglutaminases as well. The latter
enzymes catalyze an acyl transfer in which the γ-carboxamide group of an internal Gln residue
in a polypeptide acts as the acyl donor, usually to the ε-amino group of a Lys residue, resulting
in an isopeptide bond that crosslinks two polypeptides or different regions of the same
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polypeptide. There is no significant sequelogy between Ntaq1 NtQ-amidases (Figure S4) and
other proteins, including cysteine proteases or transglutaminases. Remarkably, however, we
found (using Entrez-3D and the VAST algorithm) that human Ntaq1 is spalogous (spatially
similar) to mouse peptide N-glycanase (PDB 2F4M_A) in the region of the glucanase’s
“transglutaminase core” domain. Given this result, we carried out a spatial alignment between
Ntaq1 (Figure 5A) and Factor XIII transglutaminase (Figure 6B) (Pedersen et al., 1994). The
inferred active site region of the human Ntaq1 NtQ-amidase was found to be a strikingly strong
spalog of the active site of human transglutaminase factor XIII, despite the absence of
sequelogy between these enzymes (Figure 6C; compare with Figure 6D).
In the catalysis of crosslinking by transglutaminases, the ε-amino group of a Lys residue attacks
a (transiently) enzyme-linked Gln residue of a substrate polypeptide (Pedersen et al., 1994),
but an attack by water is possible as well, leading, in such instances, to deamidation of Gln to
Glu by a transglutaminase. To examine the “converse” possibility of NtQ-amidase exhibiting
a transglutaminase activity, we employed a crosslinking assay with biotinylated cadaverin as
a source of amino group (Dutton and Singer, 1975), a Gln-DHFR reporter, and purified mouse
Ntaq1. No crosslinking of cadaverin to Gln-DHFR by Ntaq1 was observed (data not shown),
suggesting (but not proving, given the logic of negative evidence) that NtQ-amidase is devoid
of transglutaminase activity. This tentative conclusion is also consistent with the absence of
sequelogy between NtQ-amidases and transglutaminases. Taken together, our results with site-
directed mutants of NtQ-amidase (Figure 4D), the obvious spalogy (but no sequelogy) between
the active sites of NtQ-amidase and transglutaminases (Figure 6C, D), and the resulting Cys…
His…Asp catalytic triade of NtQ-amidase lead us to propose the verifiable conjecture that
deamidation of N-terminal Gln by the Ntaq1 NtQ-amidase employs a transglutaminase-like
catalytic mechanism.
DISCUSSION
Progress in biological research, including “high-throughput” structural studies, has produced
a disposition all but improbable a decade ago: the Ntaq1 NtQ-amidase, a previously undescribed
enzyme, finds itself surrounded by directly relevant genomic, proteomic and even
crystallographic evidence. These earlier data have become unified and informed in the present
work by the revealed enzymatic identity of Ntaq1, its mechanistic similarity to
transglutaminases, and its place in the N-end rule pathway. Before the present study, the
Ntaq1 gene was called Cg8253 in Drosophila melanogaster, Wdyhv1 in mice and C8orf32 in
humans (Figure 2D and Figure S5). Some of the vistas opened up by our findings about the
Ntaq1 NtQ-amidase stem from earlier data, such as, for example, the detection of putative
protein ligands of human C8orf32 (Ntaq1) ((Lim et al., 2006) and refs. therein), which remain
to be explored.
A mutant, termed tungus, in Drosophila Cg8253 (Ntaq1) that encodes the fly counterpart of
mouse NtQ-amidase, has defective long-term memory ((Dubnau et al., 2003); see also FlyBase
FBrf0188553). This finding is consistent with the previously demonstrated major role of the
N-end rule pathway in mouse brain development (An et al., 2006), with some of the putative
ligands of human C8orf32 (Ntaq1) being relevant to neurodegeneration syndromes (Lim et al.,
2006), with regulation of the nematode (C. elegans) counterpart of mouse Ntaq1 by neuron-
specific transcription factors (NCBI>GEO>Series GSE9665), and with an involvement of
human C8orf32 (Ntaq1) in regulation of genes containing cAMP-response elements (Tian et
al., 2007).
Deamidation of N-terminal Gln by NtQ-amidase (Figure 1A) is mutually exclusive with the
formation of N-terminal pyroglutamate. The latter reaction is catalyzed by glutaminyl cyclase
(Schilling et al., 2008). NtQ-amidase is present in the cytosol and the nucleus (Figure S3C–H),
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as is the rest of the N-end rule pathway, whereas glutaminyl cyclase is in the secretory
compartment, including the endoplasmic reticulum (ER). However, given complexities of
traffic between intracellular compartments (including retrotranslocation of proteins from the
ER to the cytosol), the extent of in vivo “competition” between NtQ-amidase and glutaminyl
cyclase, i.e., the extent of overlap between the sets of their physiological substrates, remains
to be determined.
Despite their multiplicity and broad range, the discovered functions of the N-end rule pathway
(see Introduction) are still the tip of the iceberg. The known physiological substrates of this
pathway (Hwang et al., 2009; Varshavsky, 2008a) are the beginning of a longer list that may
require new methods for its systematic elucidation. Given their distinct N-terminal residues,
Asn versus Gln, the sets of physiological substrates of NtN-amidase (Ntan1) and NtQ-amidase
(Ntaq1) most likely do not overlap. Therefore it is not possible to predict, at present, whether
Ntaq1−/− mice will be viable as adults, similarly to Ntan1−/− mice (Kwon et al., 2000), or
whether they will be embryonic lethals, similarly to Ate1−/− mice, which lack N-terminal
arginylation, a step downstream of N-terminal deamidation (Figure 1A) (Kwon et al., 2002).
The subunit selectivity of processive proteolysis, first discovered in the context of the N-end
rule pathway (Johnson et al., 1990), underlies most functions of the Ub system, as it allows
protein remodeling through subunit-specific degradation. A cleaved subunit whose C-terminal
fragment bears a destabilizing N-terminal residue (Figure 1A) would be a potential substrate
for selective proteolytic removal from a protein complex, thus making possible its remodeling
(Johnson et al., 1990; Prakash et al., 2009). Because the N-end rule pathway can target either
N-degrons or internal (non-N-terminal) degrons (see Introduction), this remodeling can involve
not only cleaved but also intact subunits of a protein complex. Previous work indicated that
one function of the N-end rule pathway is to operate, in such contexts, as a device that employs
its capacity for subunit-specific proteolysis to reset the states of relevant circuits. Examples
include the degradation of a separase-produced fragment of a cohesin subunit, a step that has
been shown to be required for the high fidelity of chromosome segregation (Rao et al., 2001;
Varshavsky, 2008a). Another likely example is the degradation of the yeast Mgt1 DNA
alkylguanine transferase (Hwang et al., 2009). Recent studies (Huang et al., 2006) suggested
that a circuit-resetting function of the N-end rule pathway may involve the Ntaq1-dependent
degradation of a fragment of the USP1 deubiquitylating enzyme, whose substrates include
ubiquitylated PCNA, the DNA replication processivity factor. Conditional self-cleavage of
human USP1 produces a C-terminal fragment of USP1 that bears N-terminal Gln. This
fragment is apparently short-lived in vivo (Huang et al., 2006), and may be an N-end rule
substrate targeted for degradation by the Ntaq1 NtQ-amidase. A verification of this conjecture
should be possible through the use of Ntaq1−/− mouse strains. Their construction is under way.
EXPERIMENTAL PROCEDURES
For a detailed description of Experimental Procedures, see Supplemental Data.
Reporter Proteins
In the reporter proteins His10-Ub-XLTKCEV-DHFRbt (see the legend to Figure 1B), X was
a 1-, 2-or 3-residue sequence (X = Q; E; N; EQ; MQ; GQ; REQ)
NtQ-Amidase Assay with X-DHFR Reporters
This assay was based on coupling the deamidation of N-terminal Gln to the arginylation, by
purified R-transferase, of the resulting N-terminal Glu residue (Figure 1A) in the presence of
radiolabeled Arg. The assay is outlined in Figure 1B and described in Supplemental Data.
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NtQ-Amidase Assay with Synthetic Peptides
This assay, which employed purified NtQ-amidase and 7-residue peptides XZ-GSGAW (XZ
= QH; QK; QL; QD; QY; QP; KQ; YH; NH; Ac-QH), measured deamidation-produced
ammonia using NADH-dependent glutamate dehydrogenase, as described in Supplemental
Data.
Purification of Bovine Ntaq1 NtQ-Amidase
NtQ-amidase was purified from calf brains through steps that included ion exchange,
hydrophobic and gel filtration chromatography (Figure 1C, Figure 2C, Figure S2 and S3A, B).
Mass spectrometry (MS-MS) identified a partially purified bovine NtQ-amidase as the
counterpart of a previously uncharacterized protein encoded by human C8orf32. See
Supplemental Data for details.
Plasmids for Expression of Mouse Ntaq1 in S. cerevisiae
C-terminally FLAG-tagged mouse Ntaq1 NtQ-amidase (Ntaq1f) and other proteins were
expressed in S. cerevisiae from the high-copy vector p425MET25 (Table S1)
Expression of Mouse Ntaq1 in Pichia pastoris
ORFs encoding C-terminally His6-tagged mouse Ntaq1 NtQ-amidase (Ntaq1H6) and its
missense mutants were subcloned into pPICZα-C (Table S1) and expressed in the yeast P.
pastoris, followed by purification of overexpressed proteins by Ni-affinity chromatography.
β-Galactosidase Assay
Assays for βgal activity (Baker and Varshavsky, 1995) were performed with extracts from
WHQ8 (nta1Δ) S. cerevisiae carrying pUB23-X plasmids (X = Met, Asp, Asn, Glu, or Gln)
that expressed Ub-X-βgal reporters.
Site-Directed Mutagenesis
Alterations of specific residues in mouse Ntaq1 were carried out using two-step PCR and
pPICZα-mNtaq1-mNtaq1 (Table S1).
N-terminal Sequencing of Reporter Proteins
Purified XLTKCEV-DHFRbt proteins (X = MQ; EQ; GQ; E; Q; N) were incubated with
purified mouse Ntaq1 NtQ-amidase, followed by SDS-PAGE and N-terminal sequencing of
test proteins by Edman degradation
Ntaq1-EGFP Reporter
A fusion between mouse Ntaq1 and EGFP was constructed in the pEGFP-N1 vector (Clontech)
and examined with NIH-3T3 mouse cells as described in the main text.
Antibody to Mouse Ntaq1 and Depletion of Ntaq1 from Mouse Cells and Cell Extracts
A rabbit antibody to Ntaq1 was produced using mouse Ntaq1H6 (see above) purified from P.
pastoris. The antibody was affinity-purified using immobilized Ntaq1H6, and was thereafter
employed (vis-a-vis preimmune serum) to deplete the Ntaq1 NtQ-amidase from extracts of
NIH-3T3 cells (Figure 5A, Figure S4C–E, and Supplemental Data). RNAi procedures for
down-regulation of the expression of endogenous Ntaq1 in mouse NIH-3T3 cells using pre-
microRNAs (pre-miRNAs) (Figure S4A, B) are described in Supplemental Data.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. The Ntaq1 NtQ-amidase, a Component of the N-End Rule Pathway
(A) The mammalian N-end rule pathway. N-terminal residues are indicated by single-letter
abbreviations for amino acids. Yellow ovals denote the rest of a protein substrate. “Primary”,
“secondary” and “tertiary” denote mechanistically distinct subsets of destabilizing N-terminal
residues (see Introduction). C* denotes oxidized Cys, either Cys-sulfinate or Cys-sulfonate.
The enlarged and boxed “Ntaq1” term on the lower left denotes NtQ-amidase (amidohydrolase
specific for N-terminal Gln) that was identified, isolated and characterized in the present work.
(B) NtQ-amidase assay.
(C) Purification of the bovine Ntaq1 NtQ-amidase (a condensed summary).
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Figure 2. Detection and Purification of Ntaq1 NtQ-amidase
(A) Detection of the mouse NtQ-amidase activity in cell extracts. Lane 1, SDS-PAGE of 14C-
arginylated proteins in an extract of mouse NIH-3T3 cells containing the added Glu-DHFRbt
reporter and processed as described in Figure 1B. Bands of 14C-labeled X-DHFR reporters are
indicated on the left. Lane 2, same as lane 1 but with Met-DHFRbt. Lane 3, same as lane 1 but
with Gln-DHFRbt. Lanes 4–6, same as lanes 1–3 but with mouse brain extract.
(B) 14C-arginylation assays with mouse brain extract or, alternatively, with buffer alone. These
assays were similar to the one in lanes 4–6 of panel A, but with measurements of protein-
conjugated 14C-Arg. As shown here, the arginylation of Gln-DHFRbt required a preincubation
with brain extract, whereas the arginylation of Glu-DHFRbt did not. A beads-alone control
involved incubations of brain extract or buffer alone with beads lacking a bound reporter
protein. Standard deviations, for duplicate measurements, are indicated above the bars.
(C) The last step of purification of bovine Ntaq1 NtQ-amidase, a gel filtration on Superose-12.
Only fractions near the Ntaq1 activity peak (assayed as described in Figure 1B) are shown.
Positions of Mr markers are indicated on the right of the SDS-PAGE pattern (silver staining).
The asterisk denotes fraction 32, the peak activity fraction.
(D) Enlarged image of silver-stained proteins in fraction 32 of panel C. The identities of bovine
Hebp2 and Ntaq1 were determined by mass spectrometry. A vertical arrow points to the
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sequences of specific peptides of bovine Ntaq1 that were identified this way (Hebp2 peptides
are not shown). The names of Genbank entries, in several organisms, for a protein that has now
been identified (and named) as Ntaq1 are also shown.
(E) Coomassie-stained Mr markers (lane 1) and the C-terminally His6-tagged mouse Ntaq1
NtQ-amidase (lane 2) that was purified from the yeast Pichia pastoris that overexpressed Ntaq1.
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Figure 3. In Vivo Assays of Mouse Ntaq1 in the Yeast S. cerevisiae
(A) Measurements of βgal activity in extracts of S. cerevisiae that expressed X-βgal reporters
bearing the indicated N-terminal residues were used to compare the metabolic stabilities of
these reporters in an nta1Δ S. cerevisiae strain that also carried plasmids expressing specific
Nt-amidases. 100% corresponds to the mean activity of βgal in extracts from cells expressing
Met-βgal (Ub-Met-βgal), separately for each set of X-βgal assays in A–D. Results are averages
of 3 independent measurements, which differed by less than 10% of the mean value.
(B) Same as in A but in the presence of mouse Ntaq1.
(C) Same as in A but in the presence of mouse Ntan1.
(D) Same as in A but in the presence of S. cerevisiae Nta1.
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Figure 4. The Mouse Ntaq1 Gene, the Specificity of NtQ-amidase, and Its Mutational Analysis
(A) The inferred structure of a mouse gene (Acc. No. NC_000081.5), termed Ntaq1 in the
present work, that encodes NtQ-amidase (see the main text). The inferred 3’ and 5’ untranslated
regions (UTRs) of exons 1 and 6, respectively, are indicated by open rectangles. The inferred
coding regions are in black. Their sizes, in bp, and the sizes of introns between them are also
indicated.
(B) The Q-peptide assay for NtQ-amidase activity. In this coupled enzymatic assay,
deamidation of N-terminal Gln is measured through utilization of released ammonia (NH3) by
NADH-dependent glutamate dehydrogenase (GLDH). The NH3-dependent conversion, by
GLDH, of NADH to NAD was monitored spectroscopically (see Supplemental Data).
(C) Activity of purified wild-type mouse Ntaq1 NtQ-amidase with test peptides. The Q-peptide
assay was applied to a set of indicated 7-mer peptides. The activity of Ntaq1 with Q-KGSGAW
was taken as 100%. It corresponded to 1.32 ± 0.11 nmole of Q-KGSGAW deamidated per
second per nmole of Ntaq1.
Wang et al. Page 17
Mol Cell. Author manuscript; available in PMC 2010 June 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(D) Comparisons of NtQ-amidase activity among wild-type Ntaq1 and its mutants.
Measurements were carried out using the Q-peptide assay and Q-KGSGAW. The activity of
Ntaq1E39Q (it exceeded the activity of wild-type Ntaq1) was taken as 100% in this set of tests.
That activity corresponded to 1.49 ± 0.05 nmole of peptide deamidated per second per nmole
of Ntaq1. Standard deviations, for triplicate measurements, are indicated above the bars in C
and D.
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Figure 5. Substrate Specificity of the Ntaq1 NtQ-amidase and Antibody-Mediated Depletion of
Ntaq1
(A) Depletion of NtQ-amidase activity from extracts of mouse NIH-3T3 cells by affinity-
purified antibody to mouse Ntaq1. Met-DHFRbt (white bars; this reporter cannot be
arginylated) or Gln-DHFRbt (black bars; this reporter can be arginylated after its N-terminal
deamidation) were incubated with buffer alone; or with an extract from 3T3 cells; or with the
same extract that had been depleted with preimmune serum; or with the same extract that had
been depleted with anti-Ntaq1 antibody. 14C-arginylation assay with purified R-transferase
(Figure 1B) was carried out after these treatments, followed by SDS-PAGE and
autoradiographic quantitation of a 14C-arginylated reporter band, using PhosphorImager. A
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dotted bar on the left shows the result of adding purified Ntaq1 (instead of buffer alone) to Gln-
DHFRbt, followed by 14C-arginylation. The much higher yield, in this test with purified Ntaq1,
of Arg-Glu-DHFRbt implied that the bulk of Gln-DHFRbt remained non-deamidated by
endogenous levels of the Ntaq1 NtQ-amidase in 3T3 cell extracts. Standard deviations, for
duplicate measurements, are indicated above the bars.
(B) 14C-arginylation assays (see Figure 1B), with X-DHFRbt reporters (X = M; E; Q; D; N)
and the mouse Ntaq1 NtQ-amidase purified from P. pastoris (see Figure 2E). Lanes 1–5, the
arginylation assay was carried out without preincubation with Ntaq1. Lanes 6–10, same as
lanes 1–5 but the reporters were incubated with purified mouse Ntaq1 before 14C-arginylation.
(C) N-terminal sequencing, by Edman degradation, of the indicated X-DHFRbt reporters (X
= Q; N; E; MQ; GQ; EQ) after their incubation with purified mouse Ntaq1. N-terminal Glu,
the result of Ntaq1-mediated deamidation of N-terminal Gln, is boxed in the middle row.
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Figure 6. Structural Comparison of the Ntaq1 NtQ-amidase and Factor XIII Transglutaminase
(A and B) Crystal structures of the human Ntaq1 (C8orf32) NtQ-amidase (PDB 3C9Q) (Bitto
et al., 2008) and FXIII transglutaminase (PDB 1FIE) (Pedersen et al., 1994), respectively.
C8orf32, a previously uncharacterized human protein the structure of which was deposited in
the Protein Data Bank (PDB 3C9Q) by the Center for Eukaryotic Structural Genomics (Bitto
et al., 2008), was shown, in the present work, to be the Ntaq1 NtQ-amidase.
(C and D) Structures around the active sites of Ntaq1 NtQ-amidase and Factor XIII
transglutaminase, respectively (these regions are circled in A and B). The catalytic triad of
Factor XIII transglutaminase (Cys314, His373, and Asp396) (panel D) (Pedersen et al., 1994)
and the corresponding residues of human Ntaq1 (Cys28, His81, and Asp97) (panel C) are
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indicated. Despite the striking (shown) spalogy between these regions of two enzymes, there
is no significant sequelogy between them.
(E) Structure-based sequence alignment of the human Ntaq1 NtQ-amidase (hNtaq1) and human
Factor XIII transglutaminase (FXIII). Aligned and nonaligned residues are indicated by
uppercase and lowercase letters, respectively. “-” indicates gaps in the alignment. Straight and
wavy arrows denote β-strands and α-helices, respectively. Regions in blue correspond to
aspects of active sites of these enzymes that are shown in red in A–D. See Supplemental Data
for additional details.
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